Trial intelligence / Profile preview

PK of Ferriprox in Hepatic Impairment

NCT01767103Phase 4Completed

Sponsor
ApoPharma Inc.
Start
Jan 2013
Primary completion
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of deferiprone in iron overload, sponsored by ApoPharma Inc.. Started Jan 2013; status: completed.

02

Drugs

deferiprone
03

Conditions

iron overload

Beyond the preview

Go deeper on NCT01767103.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01767103.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call